… meta-analysis that the presence of AAC uniformly increases the risk of subsequent CV events
or CV … this increment in CV risk is still evident after adjustment for traditional CV risk factors. …

… , no increases in CV events were observed … of CV events from 39 clinical trials involving
>41,000 diverse patients. The focus of this analysis was on the incidence of primary CV events …

… events (RR, 2.29; 95% CI, 1.39–3.82). When we examined major adverse cardiovascular
events, we … We considered 2 definitions of cardiovascular events: (1) all cardiovascular events, …

… on any CV events, we also summarized individual CV outcomes in the meta-analysis if at least
… All additional findings not included in the meta-analysis are listed in Supplementary Table …

… Our meta-analysis extends the findings of this analysis: including the data from those … times
the number of serious adverse cardiovascular events among participants in the varenicline …

… We did not combine the two study designs into one analysis, even if they reported on the …
meta-analysis, we determined the pooled adjusted RR equivalent for all cardiovascular events, …

… The primary outcome of this meta-analysis was time to first major cardiovascular event,
defined as fatal or nonfatal MI, fatal “other CHD,” hospitalization for unstable angina, or fatal or …

… patients and 495 cardiovascular events. Weighted … cardiovascular events (RR 0·71, 95%
CI 0·55–0·92; p=0·009), all-cause mortality (RR 0·80, 0·66–0·96; p=0·014), and cardiovascular …

… In this meta-analysis, the relative risk of cardiovascular disease was higher for an increase
of one standard deviation in HOMA-IR compared to an increase of one standard deviation in …

… We therefore systematically reviewed published literature to assess the association
between NAFLD and clinical cardiovascular events (CVE) and performed a meta-analysis. …